Tag:
HemaQuest Pharmaceuticals
Latest Headlines
Latest Headlines
HemaQuest nails $13M VC extension for sickle cell program
A little more than a year after it named a new executive team to run the company, San Diego-based HemaQuest has rounded up $13 million in new venture cash. The new investment is being referred to as...
HemaQuest books $12M Series B to advance mid-stage programs
Seattle-based HemaQuest has snared a $12 million Series B to continue its pursuit of two new drugs for orphan diseases. New investor Aberdare Ventures led the second investment round for the start-up
